TapewireFind a company

person · Reporting owner

Dudum Andrew

Disclosed activity across 1 company

Tapewire entity
18974
SEC CIK
0001837796

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Director · Chief Executive Officer · 10% ownerAugust 25, 2026August 28, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date August 25, 2026 · Filed August 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT0 Reported balance After 2026-08-25 transaction · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT463,289 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 463,289

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Legacy 2021 Trust103,406 Reported balance After 2026-08-27 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Class A Common StockSEC Table I · non-derivativeDirect1,033,177 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,033,177

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015573,202 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 573,202

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2025 GRAT dated 5-27-202542,993 Reported balance Holding disclosure · report date 2026-08-25 · row 6 Holding and transaction disclosures are not merged.
1 source row

Row 6 · Balance 42,993

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Community Property Trust470,457 Reported balance Holding disclosure · report date 2026-08-25 · row 7 Holding and transaction disclosures are not merged.
1 source row

Row 7 · Balance 470,457

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022791,117 Reported balance Holding disclosure · report date 2026-08-25 · row 8 Holding and transaction disclosures are not merged.
1 source row

Row 8 · Balance 791,117

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-20212,214,769 Reported balance Holding disclosure · report date 2026-08-25 · row 9 Holding and transaction disclosures are not merged.
1 source row

Row 9 · Balance 2,214,769

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family 2021 Trust3,004,071 Reported balance Holding disclosure · report date 2026-08-25 · row 10 Holding and transaction disclosures are not merged.
1 source row

Row 10 · Balance 3,004,071

Filing footnotes · ownership attribution and instrument terms

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 17, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 15,945 $58.50 $932,835.12
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 11

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,270

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.22 - $58.945. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 26

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,009

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F18 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 108,334 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 25

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 864,731

Underlying: Class A Common Stock · 108,334 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F17 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,710 $56.92 $1,008,012.47
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 10

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,215

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.79 - $57.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 90,624 $56.39 $5,110,196.74
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 9

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,925

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.78. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,001 $58.61 $996,404.81
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,549

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,001 $2.43 $41,312.43
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 285,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 108,334 $2.43 $263,251.62
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,414 $56.90 $421,870.69
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 237,660

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.82 - $57.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 40,120 $56.44 $2,264,428.97
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 245,074

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.83 - $56.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $56.35 $157,336.46
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,215

F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.20 - $56.495. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 13, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 19,150 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 24

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 287,256

Underlying: Class A Common Stock · 19,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F16 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

F16 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Read SEC document
June 13, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 74,530 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 23

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 819,828

Underlying: Class A Common Stock · 74,530 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
June 13, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,446 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 22

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 248,126

Underlying: Class A Common Stock · 35,446 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
June 13, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,242 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 21

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,726

Underlying: Class A Common Stock · 35,242 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F13 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F13 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
June 13, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 90,672 $55.48 $5,030,482.56
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,007

Read SEC document
June 13, 2025 Filed Jun 18, 2025 00:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 164,368 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 253,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 108,334 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 973,065

Underlying: Class A Common Stock · 108,334 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F10 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · derivative · entry 18

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,010

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,427 $59.21 $380,534.96
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 9

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,311

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.00 - $59.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 52,642 $58.67 $3,088,500.88
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,738

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.42 - $58.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 49,265 $57.84 $2,849,610.76
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,380

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.42 - $58.405. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 108,334 $2.43 $263,251.62
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 197,645

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,001 $58.72 $998,285.12
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,311

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.50 - $59.19. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,001 $2.43 $41,312.43
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,312

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 22,227 $58.70 $1,304,771.58
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 285,194

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.50 - $59.16. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 25,307 $57.86 $1,464,202.28
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 307,421

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.43 - $58.38. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 16, 2025 Filed May 19, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $59.27 $165,482.12
Disclosure

SEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,311

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.00 - $59.455. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 29, 2025 Filed Apr 30, 2025 22:01 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,081,399

Underlying: Class A Common Stock · 50,000 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
April 29, 2025 Filed Apr 30, 2025 22:01 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 50,000 $36.39 $1,819,310.00
Disclosure

SEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,103

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.07 - $36.79. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 29, 2025 Filed Apr 30, 2025 22:01 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 50,000 $2.43 $121,500.00
Disclosure

SEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
April 28, 2025 Filed Apr 30, 2025 22:01 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 41,667 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · derivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,131,399

Underlying: Class A Common Stock · 41,667 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
April 28, 2025 Filed Apr 30, 2025 22:01 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 41,667 $30.19 $1,257,760.06
Disclosure

SEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,103

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
April 28, 2025 Filed Apr 30, 2025 22:01 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 41,667 $2.43 $101,250.81
Disclosure

SEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 16,667 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,173,066

Underlying: Class A Common Stock · 16,667 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F6 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · derivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,011

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 47,534 $28.23 $1,342,093.97
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 332,728

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.885 - $28.605. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $28.31 $79,032.03
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,103

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.15 - $28.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 33,668 $28.02 $943,421.13
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,895

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.83 - $28.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 16,667 $2.43 $40,500.81
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 19:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,001 $2.43 $41,312.43
Disclosure

SEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Read SEC document
March 18, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 21,047 $34.13 $718,350.95
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,895

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F11 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.00 - $34.37. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 18, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 57,713 $33.75 $1,947,848.38
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,942

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F10 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.33 - $33.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 16,667 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 35

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,189,733

Underlying: Class A Common Stock · 16,667 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F20 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 41,667 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 34

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,206,400

Underlying: Class A Common Stock · 41,667 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F20 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 33

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,248,067

Underlying: Class A Common Stock · 50,000 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F20 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,001 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 32

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,012

Underlying: Class A Common Stock · 17,001 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F18 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,087 $34.15 $242,015.38
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 16

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 380,262

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F13 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.01 - $34.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 40,447 $33.55 $1,357,154.59
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust

Disclosed balance after: 387,349

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F12 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.20 - $33.975. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,792 $33.01 $92,159.73
Disclosure

SEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 12

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 173,655

F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.84 - $33.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.